SCHEMBL6359501

SCHEMBL6359501

O=C1CNC=C2C=CN(C(=O)O)C=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14940650 0.64 — —
SCHEMBL17338564 0.59 — —
SCHEMBL9850824 0.57 — —
SCHEMBL31481251 0.56 MEN1 (0.36) —
SCHEMBL3815799 0.55 — —
SCHEMBL31084281 0.51 — —
SCHEMBL3262997 0.47 — —
SCHEMBL5663095 0.47 — —
SCHEMBL28311023 0.46 — —
SCHEMBL4073685 0.46 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050085447-A1 Pyrido[3,4-d]pyrimidine derivatives as matrix metalloproteinase-13 inhibitors WARNER-LAMBERT COMPANY LLC 2005-04-21 — — US disclosed
WO-2005016926-A1 PYRIDO [3,4-D] PYRIMIDINE DERIVATIVES AS MATRIX METALLOPROTEINASE-13 INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2005-02-24 — — WO disclosed
Send feedback